W Chang1, Y Wu2, K Johnson2, M Loecher2, O Wieben2, M Edjlali3, C Oppenheim3, P Roca3, J Hald4, B Aagaard-Kienitz5, D Niemann6, C Mistretta2, P Turski7. 1. From the Department of Radiology (W.C.), University of California, Los Angeles, Los Angeles, California. 2. Medical Physics (Y.W., K.J., M.L., O.W., C.M.), University of Wisconsin School of Medicine, Madison, Wisconsin. 3. Department of Radiology (M.E., C.O., P.R.), Université Paris-Descartes, Paris, France. 4. Department of Radiology (J.H.), Rikshospitalet, Oslo, Norway. 5. Departments of Radiology (B.A.-K., P.T.). 6. Neurosurgery (D.N.). 7. Departments of Radiology (B.A.-K., P.T.) pturski@uwhealth.org.
Abstract
BACKGROUND AND PURPOSE: HYPRFlow is a novel imaging strategy that provides fast, high-resolution contrast-enhanced time-resolved images and measurement of the velocity of the entire cerebrovascular system. Our hypothesis was that the images obtained with this strategy are of adequate diagnostic image quality to delineate the major components of AVMs. MATERIALS AND METHODS: HYPRFlow and 3D TOF scans were obtained in 21 patients with AVMs with correlative DSA examinations in 14 patients. The examinations were scored for image quality and graded by using the Spetzler-Martin criteria. Mean arterial transit time and overlap integrals were calculated from the dynamic image data. Volume flow rates in normal arteries and AVM feeding arteries were measured from the phase contrast data. RESULTS: HYPRFlow was equivalent to 3D-TOF in delineating normal arterial anatomy, arterial feeders, and nidus size and was concordant with DSA for AVM grading and venous drainage in 13 of the 14 examinations. Mean arterial transit time on the AVM side was 0.49 seconds, and on the normal contralateral side, 2.53 seconds with P < .001. Across all 21 subjects, the mean arterial volume flow rate in the M1 segment ipsilateral to the AVM was 4.07 ± 3.04 mL/s; on the contralateral M1 segment, it was 2.09 ± 0.64 mL/s. The mean volume flow rate in the largest feeding artery to the AVM was 3.86 ± 2.74 mL/s. CONCLUSIONS: HYPRFlow provides an alternative approach to the MRA evaluation of AVMs, with the advantages of increased coverage, 0.75-second temporal resolution, 0.68-mm isotropic spatial resolution, and quantitative measurement of flow in 6 minutes.
BACKGROUND AND PURPOSE: HYPRFlow is a novel imaging strategy that provides fast, high-resolution contrast-enhanced time-resolved images and measurement of the velocity of the entire cerebrovascular system. Our hypothesis was that the images obtained with this strategy are of adequate diagnostic image quality to delineate the major components of AVMs. MATERIALS AND METHODS: HYPRFlow and 3D TOF scans were obtained in 21 patients with AVMs with correlative DSA examinations in 14 patients. The examinations were scored for image quality and graded by using the Spetzler-Martin criteria. Mean arterial transit time and overlap integrals were calculated from the dynamic image data. Volume flow rates in normal arteries and AVM feeding arteries were measured from the phase contrast data. RESULTS: HYPRFlow was equivalent to 3D-TOF in delineating normal arterial anatomy, arterial feeders, and nidus size and was concordant with DSA for AVM grading and venous drainage in 13 of the 14 examinations. Mean arterial transit time on the AVM side was 0.49 seconds, and on the normal contralateral side, 2.53 seconds with P < .001. Across all 21 subjects, the mean arterial volume flow rate in the M1 segment ipsilateral to the AVM was 4.07 ± 3.04 mL/s; on the contralateral M1 segment, it was 2.09 ± 0.64 mL/s. The mean volume flow rate in the largest feeding artery to the AVM was 3.86 ± 2.74 mL/s. CONCLUSIONS: HYPRFlow provides an alternative approach to the MRA evaluation of AVMs, with the advantages of increased coverage, 0.75-second temporal resolution, 0.68-mm isotropic spatial resolution, and quantitative measurement of flow in 6 minutes.
Authors: D R Buis; J C J Bot; F Barkhof; D L Knol; F J Lagerwaard; B J Slotman; W P Vandertop; R van den Berg Journal: AJNR Am J Neuroradiol Date: 2011-11-17 Impact factor: 3.825
Authors: D R Hadizadeh; G M Kukuk; D T Steck; J Gieseke; H Urbach; H J Tschampa; S Greschus; A Kovàcs; M Möhlenbruch; A Bostroem; H H Schild; W A Willinek Journal: AJNR Am J Neuroradiol Date: 2012-02-02 Impact factor: 3.825
Authors: Michael Markl; Can Wu; Michael C Hurley; Sameer A Ansari; Timothy J Carroll; Rudy J Rahme; Salah G Aoun; James Carr; Hunt Batjer; Bernard R Bendok Journal: J Magn Reson Imaging Date: 2013-09-11 Impact factor: 4.813
Authors: Huimin Wu; Walter F Block; Patrick A Turski; Charles A Mistretta; David J Rusinak; Yijing Wu; Kevin M Johnson Journal: J Magn Reson Imaging Date: 2013-10-15 Impact factor: 4.813
Authors: Yijing Wu; Kevin Johnson; Steven R Kecskemeti; Kang Wang; Oliver Wieben; Beverly L Aagaard-Kienitz; Howard Rowley; Frank R Korosec; Charles Mistretta; Patrick Turski Journal: Magn Reson Med Date: 2011-02-17 Impact factor: 4.668
Authors: Kevin M Johnson; Chris Francois; Darren Lum; Thorsten A Bley; Elisabeth Nett; Benjamin Landgraf; Scott B Reeder; Thomas M Grist; Oliver Wieben Journal: Annu Int Conf IEEE Eng Med Biol Soc Date: 2009
Authors: Christopher S Eddleman; Hyun J Jeong; Michael C Hurley; Sven Zuehlsdorff; Guilherme Dabus; Christopher G Getch; H Hunt Batjer; Bernard R Bendok; Timothy J Carroll Journal: Stroke Date: 2009-05-28 Impact factor: 7.914
Authors: S A Ansari; S Schnell; T Carroll; P Vakil; M C Hurley; C Wu; J Carr; B R Bendok; H Batjer; M Markl Journal: AJNR Am J Neuroradiol Date: 2013-05-02 Impact factor: 3.825
Authors: Zachary Clark; Kevin M Johnson; Yijing Wu; Myriam Edjlali; Charles Mistretta; Oliver Wieben; Patrick Turski Journal: Invest Radiol Date: 2016-06 Impact factor: 6.016
Authors: Tilman Schubert; Yijing Wu; Kevin M Johnson; Oliver Wieben; Jane Maksimovic; Charles Mistretta; Patrick Turski Journal: Invest Radiol Date: 2016-11 Impact factor: 6.016
Authors: M Markl; S Schnell; C Wu; E Bollache; K Jarvis; A J Barker; J D Robinson; C K Rigsby Journal: Clin Radiol Date: 2016-03-02 Impact factor: 2.350
Authors: Tobias Greve; Felix Ehret; Theresa Hofmann; Jun Thorsteinsdottir; Franziska Dorn; Viktor Švigelj; Anita Resman-Gašperšič; Joerg-Christian Tonn; Christian Schichor; Alexander Muacevic Journal: Front Oncol Date: 2021-03-09 Impact factor: 6.244